Search alternatives:
increase decrease » increased release (Expand Search), increased crash (Expand Search)
test decrease » teer decrease (Expand Search), cost decreased (Expand Search), step decrease (Expand Search)
increase decrease » increased release (Expand Search), increased crash (Expand Search)
test decrease » teer decrease (Expand Search), cost decreased (Expand Search), step decrease (Expand Search)
-
1621
Clinical characteristics.
Published 2025“…Survival curves were estimated using the Kaplan-Meier plot and compared using the Log-rank test.</p><p>Results</p><p>Mean age at T2D diagnosis was significantly lower in the FHD group, while time to insulin initiation was independent from FHD status. …”
-
1622
-
1623
-
1624
-
1625
-
1626
-
1627
Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA. Positive effect sizes indicate an increase in metabolite concentration between the compared groups, while negative values indicate a decrease.
Published 2025“…Positive effect sizes indicate an increase in metabolite concentration between the compared groups, while negative values indicate a decrease.…”
-
1628
Data.
Published 2025“…This study found a statistically significant decrease in BMD in the group with the lowest U-Cd levels (<2.0 μg/g creatinine, p = 0.001) and in the overall sample (from 0.392 ± 0.079 μg/g creatinine in 2019 to 0.384 ± 0.094 μg/g creatinine in 2022, p = 0.004). …”
-
1629
-
1630
-
1631
-
1632
-
1633
-
1634
-
1635
-
1636
-
1637
-
1638
-
1639
-
1640
Indications for warfarin prescription in outpatients and inpatients in 2023.
Published 2025Subjects: